N. Vargesson

Molecular Biology · 2015

A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 5 researchers here, as inferred from the citation graph.

Subfields

Whom N. Vargesson trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. R. Adams

Who trusts N. Vargesson overall

  1. Zhenling Liu
  2. Huanhuan Chen
  3. Clémence Réda
  4. Li-li Zheng
  5. Li-Ping Sun

Papers from N. Vargesson's perspective

Ordered by how strongly the researchers N. Vargesson trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Structure of the human Cereblon–DDB1–lenalidomide complex reveals basis for responsiveness to thalidomide analogs
  2. The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins (Science)
  3. Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells (Science)
  4. Identification of a Primary Target of Thalidomide Teratogenicity (Science)
  5. Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone (Nature)
  6. Endothelial Notch activity promotes angiogenesis and osteogenesis in bone (Nature)
  7. Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases (Cancer Cell)
  8. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation (Cancer Cell)
  9. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate (Nature)
  10. Role of Tet proteins in 5mC to 5hmC conversion, ES cell self-renewal, and ICM specification (Nature)

Their papers